期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 61, 期 12, 页码 5222-5234出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b00026
关键词
-
资金
- National Science Centre in Poland [2017/25/B/STS/00215]
- Foundation for Polish Science
- European Union under the European Regional Development Fund
- European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [661187]
- Marie Curie Actions (MSCA) [661187] Funding Source: Marie Curie Actions (MSCA)
The proteasome is an enzyme complex critical for maintaining protein homeostasis. Perturbed proteasome function leads to pathologies including cancer and autoimmune and neurodegenerative disease. Therefore, the proteasome constitutes an excellent molecular target for pharmaceutical development. Here, using the HyCoSuL approach, we designed and synthesized novel and selective fluorogenic substrates for each of these three constitutive 20S proteasome activities and applied them to assess inhibition of proteasome subunits by MG-132 and a clinically used inhibitor bortezomib. Our results confirm the utility of designed substrates in biochemical assays. Furthermore, selective peptide sequences obtained in this manner were used to construct fluorophore-labeled activity-based probes and then utilized to detect each constitutive 20S proteasome subunit simultaneously in lysates of HEK-293F cells and red blood cells. Overall, we describe a simple and rapid method useful to measure constitutive 20S proteasome activity in whole human blood samples that could enable early diagnosis of pathological states associated with aberrantly upregulated proteasome activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据